0001209191-20-001811.txt : 20200106 0001209191-20-001811.hdr.sgml : 20200106 20200106162417 ACCESSION NUMBER: 0001209191-20-001811 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200102 FILED AS OF DATE: 20200106 DATE AS OF CHANGE: 20200106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: THOMAS FRANK E CENTRAL INDEX KEY: 0001242616 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38722 FILM NUMBER: 20510021 MAIL ADDRESS: STREET 1: C/O AMAG PHARMACEUTICALS, INC. STREET 2: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Orchard Therapeutics plc CENTRAL INDEX KEY: 0001748907 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 108 CANNON STREET CITY: LONDON STATE: X0 ZIP: EC4N 6EU BUSINESS PHONE: 011-44-0-203-3846700 MAIL ADDRESS: STREET 1: 108 CANNON STREET CITY: LONDON STATE: X0 ZIP: EC4N 6EU FORMER COMPANY: FORMER CONFORMED NAME: Orchard Rx Ltd DATE OF NAME CHANGE: 20180802 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-02 0 0001748907 Orchard Therapeutics plc ORTX 0001242616 THOMAS FRANK E C/O ORCHARD THERAPEUTICS PLC 108 CANNON STREET LONDON X0 EC4N 6EU UNITED KINGDOM 0 1 0 0 See Remarks Stock Option (Right to Buy) 13.58 2020-01-02 4 A 0 200000 0.00 A 2030-01-01 Ordinary Shares 200000 200000 D The shares subject to this option vest in equal monthly installments over the four years after January 2, 2020. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Title: Chief Financial Officer and Chief Operating Officer /s/ Frank E. Thomas 2020-01-06